Active: Response to antipsychotic treatment Clear all

GWAS 2024-11-19

Refining antipsychotic treatment strategies in schizophrenia: discovery of genetic biomarkers for enhanced drug response prediction.

Chen L, Huai C et al.

Mol Psychiatry

Schizophrenia (SCZ) is a severe mental disorder affecting around 1% of individuals worldwide. The va...

Response to antipsychotic treatment in schizophrenia

2114

Participants

N/A

Studies

Details PubMed

GWAS 2021-04-29

Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.

Weng S, Wang B et al.

PLoS One

Second-generation antipsychotics (SGAs) play a critical role in current treatment of schizophrenia (...

Response to antipsychotic treatment in schizophrenia (sinus bradycardia)

Participants

N/A

Studies

Details PubMed

GWAS 2018-03-01

Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.

Yu H, Yan H et al.

Lancet Psychiatry

Antipsychotic drugs improve schizophrenia symptoms and reduce the frequency of relapse, but treatmen...

Response to antipsychotic treatment in schizophrenia

Replicated

3792

Participants

N/A

Studies

Details PubMed

GWAS 2012-12-12

Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.

Clark SL, Souza RP et al.

Pharmacogenet Genomics

Objective: To examine the unique and congruent findings between multiple raters in a genome-wide ass...

Response to antipsychotic treatment

738

Participants

N/A

Studies

Details PubMed

GWAS 2010-11-24

Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

McClay JL, Adkins DE et al.

Neuropsychopharmacology

Neurocognitive deficits are a core feature of schizophrenia and, therefore, represent potentially cr...

Response to antipsychotic treatment in schizophrenia (working memory)

738

Participants

N/A

Studies

Details PubMed

GWAS 2010-03-02

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.

Adkins DE, Aberg K et al.

Mol Psychiatry

Understanding individual differences in the susceptibility to metabolic side effects as a response t...

Response to antipsychotic treatment

738

Participants

N/A

Studies

Details PubMed

GWAS 2009-09-01

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

McClay JL, Adkins DE et al.

Mol Psychiatry

Schizophrenia is an often devastating neuropsychiatric illness. Understanding the genetic variation ...

Response to antipsychotic treatment

738

Participants

N/A

Studies

Details PubMed

GWAS 2009-08-13

Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients.

Alkelai A, Greenbaum L et al.

Psychopharmacology (Berl)

Rationale: Antipsychotic-induced parkinsonism (AIP) is a severe adverse affect of neuroleptic treatm...

Response to antipsychotic treatment

397

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

Refining antipsychotic treatment strategies in schizophrenia: discovery of genetic biomarkers for enhanced drug response prediction.

Chen L, Huai C et al.

Mol Psychiatry

Response to antipsychotic treatment in schizophrenia

2024-11-19

Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.

Weng S, Wang B et al.

PLoS One

Response to antipsychotic treatment in schizophrenia (sinus bradycardia)

2021-04-29

Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.

Yu H, Yan H et al.

Lancet Psychiatry

Response to antipsychotic treatment in schizophrenia

2018-03-01

Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.

Clark SL, Souza RP et al.

Pharmacogenet Genomics

Response to antipsychotic treatment

2012-12-12

Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

McClay JL, Adkins DE et al.

Neuropsychopharmacology

Response to antipsychotic treatment in schizophrenia (working memory)

2010-11-24

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.

Adkins DE, Aberg K et al.

Mol Psychiatry

Response to antipsychotic treatment

2010-03-02

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

McClay JL, Adkins DE et al.

Mol Psychiatry

Response to antipsychotic treatment

2009-09-01

Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients.

Alkelai A, Greenbaum L et al.

Psychopharmacology (Berl)

Response to antipsychotic treatment

2009-08-13